Controlled enhancement or suppression of exchange biasing using impurity δ\delta-layers

The effects of inserting impurity $\delta$-layers of various elements into a Co/IrMn exchange biased bilayer, at both the interface, and at given points within the IrMn layer a distance from the interface, has been investigated. Depending on the chemical species of dopant, and its position, we found that the exchange biasing can be either strongly enhanced or suppressed. We show that biasing is enhanced with a dusting of certain magnetic impurities, present at either at the interface or sufficiently far away from the Co/IrMn interface. This illustrates that the final spin structure at the Co/IrMn interface is not only governed by interface structure/roughness but is also mediated by local exchange or anisotropy variations within the bulk of the IrMn

Analytical solution of the equation of motion for a rigid domain wall in a magnetic material with perpendicular anisotropy

This paper reports the solution of the equation of motion for a domain wall in a magnetic material which exhibits high magneto-crystalline anisotropy. Starting from the Landau-Lifschitz-Gilbert equation for field-induced motion, we solve the equation to give an analytical expression, which specifies the domain wall position as a function of time. Taking parameters from a Co/Pt multilayer system, we find good quantitative agreement between calculated and experimentally determined wall velocities, and show that high field uniform wall motion occurs when wall rigidity is assumed.Comment: 4 pages, 4 figure

Exchange anisotropy pinning of a standing spin wave mode

Standing spin waves in a thin film are used as sensitive probes of interface pinning induced by an antiferromagnet through exchange anisotropy. Using coplanar waveguide ferromagnetic resonance, pinning of the lowest energy spin wave thickness mode in Ni(80)Fe(20)/Ir(25)Mn(75) exchange biased bilayers was studied for a range of IrMn thicknesses. We show that pinning of the standing mode can be used to amplify, relative to the fundamental resonance, frequency shifts associated with exchange bias. The shifts provide a unique `fingerprint' of the exchange bias and can be interpreted in terms of an effective ferromagnetic film thickness and ferromagnet/antiferromagnet interface anisotropy. Thermal effects are studied for ultra-thin antiferromagnetic Ir(25)Mn(75) thicknesses, and the onset of bias is correlated with changes in the pinning fields. The pinning strength magnitude is found to grow with cooling of the sample, while the effective ferromagnetic film thickness simultaneously decreases. These results suggest that exchange bias involves some deformation of magnetic order in the interface region.Comment: 7 pages, 7 figure

Durable low surface-energy surfaces

A formulation for forming a low surface-energy surface on a substrate having (i) a fluoroalkyl silane having a low surface energy part, (ii) a liquid crystal silane operable for enhancing the orientation of the molecules of the fluoroalkyl silane and for crosslinking with the fluoroalkyl silane, and, (iii) a transport medium for applying the fluoroalkyl silane and the liquid crystal silane to the surface of a substrate. In one embodiment the formulation can includes a crosslinking agent for crosslinking the fluoroalkyl silane. In another embodiment the formulation has a condensation catalyst for enhancing chemical bonding of the fluoroalkyl silane to the substrate. The transport medium can be an alcohol such as methanol or ethanol

The deleterious effect of arteriovenous flow reversal during experimental free muscle transfer.

Arteriovenous flow reversal (AVR) has been used experimentally to salvage ischemic limbs and to create novel skin flaps with some success. The clinical applicability of AVR in muscle by way of two arteriovenous anastomoses in the rabbit was investigated. Twenty-four rabbits were divided into two groups. In Group 1 (control), the rectus femoris muscle was harvested and transplanted in the opposite thigh, anastomosing the donor femoral artery to the recipient femoral artery, and the donor rectus femoris vein to the recipient femoral vein. In Group 2 (flow reversal), the same procedure was done except the donor artery was anastomosed to the recipient vein and vice versa. Six and 24 hr postoperatively, specimens were compared macroscopically and by weight and histology. Reversed flow muscles were significantly heavier than control muscles at 6 hr and at 24 hr. Histologically, 6 hr of AVR caused edema, intramuscular hemorrhage, neutrophil infiltration, and thrombosis of most vessels. By 24 hr muscle cell degeneration was well advanced. All control muscles were viable, with only mild edema and slight peripheral necrosis. Possible reasons for the failure of AVR in muscle are discussed. On the basis of these results, AVR in free muscle transfer is not advocated

The Route of Sir John Franklin's Third Arctic Expedition: An Evaluation and Test of an Alternative Hypothesis

An archaeological survey to aid in the determination of the exact route of the last Sir John Franklin expedition following its overwintering at Beechey Island in 1845-46 was conducted in June 1982. The survey was designed to test the hypothesis that the expedition sailed from Beechey Island south to King William Island via McClintock Channel, rather than through Peel Sound and Franklin Strait, as is generally accepted. Surveyed areas included Kilian, Stefansson, and northeast Victoria Islands in northwest McClintock Channel, and Russell and northern Prince of Wales Islands to the northeast of McClintock Channel. Although three cairns associated with Austin's searching expedition of 1850-51 were located, as well as several prehistoric and historic Inuit sites, no structures or materials associated with the Franklin expedition were identified. While inconclusive, the survey essentially completes the examination of coastlines along which the Franklin expedition may have sailed.Key words: Sir John Franklin, route of third arctic expedition, McClintock ChannelEn juin 1982, on a effectué une étude archéologique destinée à permettre de retracer la route empruntée par la dernière expédition de sir John Franklin après le long hivernage de 1845-46 à l'île Beechey. L'étude avait pour but de vérifier l'hypothèse selon laquelle l'expédition avait navigué de l'île Beechey en direction du sud vers l'île du Roi-Guillaume via le chenal McClintock, plutôt qu'à travers le détroit de Peel et celui de Franklin, comme on le pense habituellement. Les régions de l'étude comprenaient les îles Kilian et Stefansson et le nord-est de l'île Victoria dans la partie nord-ouest du chenal McClintock, ainsi que l'île Russell et la partie septentrionale de l'île du Prince-de-Galles au nord-est du chenal McClintock. Bien qu'on ait localisé trois cairns datant de l'expédition de recherche menée par Austin en 1850-51, ainsi que divers sites inuit préhistoriques et historiques, on n'a pu identifier ni structure ni matériaux remontant à l'expédition Franklin. Si l'étude n'a pas abouti à une conclusion définitive, elle a du moins permis de compléter l'examen du rivage côtier le long duquel l'expédition Franklin a pu naviguer.Mots clés: sir John Franklin, route de la troisième expédition arctique, chenal McClintoc

Formulation development of a recombinant protein based non-replicating rotavirus (NRRV) vaccine candidate: Antigen-adjuvant-preservative interactions

Rotavirus is the leading cause of acute diarrhea and gastroenteritis among infants and young children worldwide. Over 215,000 children under five years of age die from rotavirus infection each year, mostly in developing world1. Currently two live attenuated oral rotavirus vaccines are available globally (Rotarix® and RotaTeq®) to reduce the burden of this disease with an efficacy of \u3e90% in developed countries2. Vaccine efficacy is lower, however, in developing countries due to a variety of factors3. To this end, a non-replicating rotavirus (NRRV) vaccine candidate, containing three recombinant protein antigens (P2-VP8-P[4], P2-VP8-P[6] and P2-VP8-P[8]), is being developed by PATH and its partners as a trivalent vaccine for use in the developing world4. This trivalent rotavirus vaccine candidate includes the three antigens from the most prevalent serotypes associated with \u3e90% of rotavirus gastroenteritis worldwide. In the present study, the following formulation development issues were examined: (1) establish stability-indicating physicochemical assays for a NRRV protein antigen (P[8]) bound to an aluminum hydroxide adjuvant (Alhydrogel®), which include primary and higher-order structures, chemical and conformational stability of the protein on Alhydrogel, and the ability to desorb the antigen from Alhydrogel; (2) examine the adsorptive capacity and coefficients of Alhydrogel® for the P[8] antigen in several candidate drug product formulations; (3) investigate the effects of binding to Alhydrogel® and the addition of two antimicrobial preservatives (2-phenoxyethanol or thimerosal) on the structural integrity and conformational stability of P[8], the latter of which were found to be potent destabilizers of the antigen; and (4) monitor the real-time and accelerated storage stability over 3 months of P[8] bound to Alhydrogel® in several candidate formulations with and without thimerosal at different temperatures. In the absence of preservative, the P[8] protein antigen was overall stable with only a small amount of Asn deamidation observed in samples stored under real-time (4˚C) or accelerated (25˚C) temperatures. Similarly, little (if any) changes were observed in the real-time stability of the antigen on Alhydrogel® in the presence of thimerosal. Under accelerated storage temperatures (25 or 37˚C) however, the preservative caused an increase in inter-molecular disulfide bonding, decrease of apparent enthalpy as measured by DSC, and a decrease in in-vitro antigenicity. Similar stability studies are currently ongoing with the P[4] and P[6] protein antigens. Acknowledgements: Funding provided by the Bill & Melinda Gates Foundation References: 1. Tate et al 2016. Clinical Infectious Diseases 62:S96-S105 2. Tissera et al. 2017. Human Vaccines & Immunotherapeutics 13(4):921-927 3. Glass et al. 2014. Journal of Infection 68: S9-S18. 4. Groome et al. 2017. Lancet Infectious Diseases17(8): 843-853